In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...

March 28 (Reuters) - Origin Technologies Corp, owned by Affymetrix Inc's former employees, withdrew its offer to buy the gene sequencing products maker, hours after Affymetrix said Origin's raised ...

Affymetrix Inc. on Wednesday postponed a vote on its proposed tie-up with Thermo Fisher Scientific Inc.,TMO-1.64%decrease; red down pointing triangle saying a new unsolicited bid from Origin ...

A group of former Affymetrix Inc. executives on Tuesday raised its offer for the genetic-analysis company by 5.6% in another attempt to disrupt the planned tie-up with Thermo Fisher Scientific Inc.

Newly-formed Origin Technologies is now offering $17/share in cash for Affymetrix (NASDAQ:AFFX), up from a prior $16.10/share. Origin has also upped the size of its reverse termination fee to $100M, ...

(Reuters) - Thermo Fisher Scientific Inc sent a letter to Affymetrix Inc shareholders on Tuesday, reiterating its argument that its $1.3 billion agreement to acquire the U.S. gene-testing company is ...

Thermo Fisher Scientific, Inc.TMO issued an open letter to the shareholders of Affymetrix Inc. AFFX, after the latter received a takeover bid from Origin Technologies on Mar 18, 2016. Origin's bid to ...

) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified Affymetrix ...

Scientific equipment giant set to acquire developer of genotyping and flow cytometry technology for $1.3 billion amid major backing for new cancer diagnostic efforts. Affymetrix, the ...